Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova (K)

Sentiment:

SEC Form 4 Filing


The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova (K) at a price of $82.4727 per share on April 28, 2025, according to a Form 4 filing.

Summary

  • On April 28, 2025, the W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova (K) common stock.
  • The sale price was $82.4727 per share.
  • Following the transaction, the Trust beneficially owns 46,930,782 shares of Kellanova.
  • The sales were made pursuant to trading instructions given by the W.K. Kellogg Foundation Trust on May 7, 2024, intended to comply with Rule 10b5-1(c) under the Securities and Exchange Act of 1934.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing related to a share sale. The use of a 10b5-1 plan suggests the sale was pre-planned and doesn't necessarily indicate a negative outlook on the company.

Industry Context

Sales by major shareholders are common and can be for a variety of reasons, including diversification or philanthropic purposes. The use of a 10b5-1 trading plan suggests the sale was pre-planned.

Stakeholder Impact

  • The sale of shares by a major shareholder could have a minor impact on investor sentiment.

Key Dates

DateDescription
August 30, 2017Date of Power of Attorney granted to Craig R. Carberry.
May 7, 2024Date trading instructions were given by the W.K. Kellogg Foundation Trust.
April 28, 2025Date of the transaction (sale of shares).

Keywords

Kellanova, Kellogg W K Foundation Trust, Form 4, share sale, beneficial ownership, Rule 10b5-1(c), trading plan

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.